Helios-expressing CD8+ T cells are decreased in patients with systemic lupus erythematosus. 2021

Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
Department of Hematology, Oncology, Immunoncology and Rheumatology, Internal Medicine III, University Hospital Bonn, Germany.

UI MeSH Term Description Entries
D008180 Lupus Erythematosus, Systemic A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow. Libman-Sacks Disease,Lupus Erythematosus Disseminatus,Systemic Lupus Erythematosus,Disease, Libman-Sacks,Libman Sacks Disease
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D005434 Flow Cytometry Technique using an instrument system for making, processing, and displaying one or more measurements on individual cells obtained from a cell suspension. Cells are usually stained with one or more fluorescent dyes specific to cell components of interest, e.g., DNA, and fluorescence of each cell is measured as it rapidly transverses the excitation beam (laser or mercury arc lamp). Fluorescence provides a quantitative measure of various biochemical and biophysical properties of the cell, as well as a basis for cell sorting. Other measurable optical parameters include light absorption and light scattering, the latter being applicable to the measurement of cell size, shape, density, granularity, and stain uptake. Cytofluorometry, Flow,Cytometry, Flow,Flow Microfluorimetry,Fluorescence-Activated Cell Sorting,Microfluorometry, Flow,Cell Sorting, Fluorescence-Activated,Cell Sortings, Fluorescence-Activated,Cytofluorometries, Flow,Cytometries, Flow,Flow Cytofluorometries,Flow Cytofluorometry,Flow Cytometries,Flow Microfluorometries,Flow Microfluorometry,Fluorescence Activated Cell Sorting,Fluorescence-Activated Cell Sortings,Microfluorimetry, Flow,Microfluorometries, Flow,Sorting, Fluorescence-Activated Cell,Sortings, Fluorescence-Activated Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D016022 Case-Control Studies Comparisons that start with the identification of persons with the disease or outcome of interest and a control (comparison, referent) group without the disease or outcome of interest. The relationship of an attribute is examined by comparing both groups with regard to the frequency or levels of outcome over time. Case-Base Studies,Case-Comparison Studies,Case-Referent Studies,Matched Case-Control Studies,Nested Case-Control Studies,Case Control Studies,Case-Compeer Studies,Case-Referrent Studies,Case Base Studies,Case Comparison Studies,Case Control Study,Case Referent Studies,Case Referrent Studies,Case-Comparison Study,Case-Control Studies, Matched,Case-Control Studies, Nested,Case-Control Study,Case-Control Study, Matched,Case-Control Study, Nested,Case-Referent Study,Case-Referrent Study,Matched Case Control Studies,Matched Case-Control Study,Nested Case Control Studies,Nested Case-Control Study,Studies, Case Control,Studies, Case-Base,Studies, Case-Comparison,Studies, Case-Compeer,Studies, Case-Control,Studies, Case-Referent,Studies, Case-Referrent,Studies, Matched Case-Control,Studies, Nested Case-Control,Study, Case Control,Study, Case-Comparison,Study, Case-Control,Study, Case-Referent,Study, Case-Referrent,Study, Matched Case-Control,Study, Nested Case-Control
D051740 Ikaros Transcription Factor A transcription factor that plays a role as a key regulator of HEMATOPOIESIS. Aberrant Ikaros expression has been associated with LYMPHOBLASTIC LEUKEMIA. Ikaros Protein,Transcription Factor, Ikaros

Related Publications

Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
September 2013, Annals of the rheumatic diseases,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
September 2012, Rheumatology (Oxford, England),
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
January 2024, Frontiers in immunology,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
July 2008, Lupus,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
February 2004, Scandinavian journal of immunology,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
March 2022, BMC immunology,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
January 2023, Frontiers in immunology,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
September 2006, Journal of autoimmunity,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
August 2014, The American journal of the medical sciences,
Tobias Aw Holderried, and Mareike Kruse, and Michael Serries, and Peter Brossart, and Dominik Wolf, and Anna Maria Wolf
January 2024, Clinical and experimental medicine,
Copied contents to your clipboard!